Make provision about methods of testing the safety of medicines; and for connected purposes.
The Bill proposes the establishment of a Medicines Safety Evaluation Panel to compare the effectiveness of human biology-based tests and animal-based tests in assessing the safety of medicines. The panel would be required to report within two years and would have full access to all relevant records held by the Medicines and Healthcare Products Regulatory Agency.
House of Commons
1 May 2012
The bill would set up a Medicines Safety Evaluation Panel to compare how well tests based on human biology work with traditional animal tests for medicine safety. The panel would have full access to MHRA records and must report its findings within two years. Its work could influence future testing methods and how medicines are regulated.
The bill is currently at the second reading in the House of Commons and originated there; it would proceed to committee stage if it advances.
Generated 21 February 2026
No recorded votes for this bill yet.
